Mode
Text Size
Log in / Sign up
N/A N=38 Randomized Basic Science

A Clinical Investigation Evaluating Three New 1-piece Ostomy Products

Ileostomy - Stoma

Enrolled (actual)
38
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcome: Primary: Trans Epidermal Water Loss — 19.6; 20.7; 24.1 g/m^2/h

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Ostomy device 1 (Device); Ostomy device 2 (Device); Ostomy device 3 (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Coloplast A/S
Primary completion
Feb 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Trans Epidermal Water Loss
19.6; 20.7; 24.1

Summary

This investigation evaluates three new ostomy appliances and their impact on the peristomal skin.

Eligibility Criteria

Inclusion Criteria

  • Have given written informed consent and in DK: signed a letter of authority
  • Be at least 18 years of age and have full legal capacity
  • Have had their ileostomy for at least 3 months
  • Have an ileostomy with a diameter between 10 and 55 mm
  • Be able to handle the Clinical App. and product themselves
  • Must be able to use custom cut product
  • Minimum change of product every second day
  • If current product is SenSura Mio - Be willing to use Maxi bag during investigation
  • Subject using Sensura or Sensura Mio flat 1 pc. open for at least two weeks before inclusion in the study.
  • Negative result of a pregnancy test for women of childbearing age (only DK)

Exclusion Criteria

  • Are currently receiving or have within the past 2 months received radio-and/or chemotherapy (low doses chemotherapy are allowed for other indications than cancer, e.g. below 15 mg methotrexate for rheumatoid arthritis)
  • Are currently receiving or have within the past month received topical steroid treatment in the peristomal skin area, e.g. lotion or spray. Systemic steroid treatment (e.g. injection, or tablet) are allowed.
  • Are pregnant or breastfeeding**
  • Are participating in other interventional clinical investigations or have previously participated in this investigation
  • Are currently suffering from peristomal skin problems i.e. bleeding and/or broken skin (assessed by the investigator)
  • Have known hypersensitivity towards any of the products used in the investigation
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03154944). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search